Eric Sherman, MD
Memorial Sloan Kettering Cancer Center
4
4
1
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Marco Raffaelli, Prof
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Shared therapeutic areas:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
Wendy Demark-Wahnefried, PhD, RD
University of Alabama at Birmingham
Shared therapeutic areas:
Lin Liao, MD
Qianfoshan Hospital
Shared therapeutic areas:
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Marie-France Langlois, MD
Université de Sherbrooke
Shared therapeutic areas:
Yueh Lee, MD, PhD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Shared therapeutic areas:
Kiyohiko Mabuchi, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Weijun Wei, Ph.D. & M.D.
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
All 4 trials loaded